Transcriptional profiles define drug refractory disease in myeloma

Identifying biomarkers associated with disease progression and drug resistance are important for personalized care. We investigated the expression of 121 curated genes, related to immunomodulatory drugs (IMiDs) and proteasome inhibitors (PIs) responsiveness. We analyzed 28 human multiple myeloma (MM...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yuan Xiao, Bruins, Laura A., Chen, Xianfeng, Shi, Chang‐Xin, Bonolo De Campos, Cecilia, Meurice, Nathalie, Wang, Xuewei, Ahmann, Greg J., Ramsower, Colleen A., Braggio, Esteban, Rimsza, Lisa M., Stewart, A. Keith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Haematologic Malignancy ‐ Plasma Cell
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422020/
https://www.ncbi.nlm.nih.gov/pubmed/36051067
http://dx.doi.org/10.1002/jha2.455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422020/
https://www.ncbi.nlm.nih.gov/pubmed/36051067
http://dx.doi.org/10.1002/jha2.455

Ejemplares similares